Literature DB >> 19027613

Interleukin 17-producing T helper cells in alloimmunity.

Fleur Samantha Benghiat1, Louis Marie Charbonnier, Benoit Vokaer, Virginie De Wilde, Alain Le Moine.   

Abstract

Interleukin (IL) 17 is a proinflammatory cytokine already known to play a defense role against microbes and a pathogenic role in a number of autoimmune diseases. Although IL-17 can be produced by a variety of cells including neutrophils, CD8+, NK, and gamma-delta T cells, the concept of IL-17-secreting CD4+ T helper cells (Th17), distinct from Th1 and Th2, recently emerged. Herein, we discuss arguments in favor of a Th17-mediated alternative pathway of allograft rejection based on clinical and experimental observations drawn from the literature. We also discuss the complex interplays among regulatory T cells and Th17 cells in the allogeneic context.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19027613     DOI: 10.1016/j.trre.2008.08.007

Source DB:  PubMed          Journal:  Transplant Rev (Orlando)        ISSN: 0955-470X            Impact factor:   3.943


  11 in total

Review 1.  Graft rejection - endogenous or allogeneic?

Authors:  William R Critchley; James E Fildes
Journal:  Immunology       Date:  2012-06       Impact factor: 7.397

Review 2.  Role and mechanism of action of complement in regulating T cell immunity.

Authors:  Jason R Dunkelberger; Wen-Chao Song
Journal:  Mol Immunol       Date:  2010-06-18       Impact factor: 4.407

Review 3.  Review: The function of regulatory T cells at the ocular surface.

Authors:  William Foulsham; Anna Marmalidou; Afsaneh Amouzegar; Giulia Coco; Yihe Chen; Reza Dana
Journal:  Ocul Surf       Date:  2017-05-31       Impact factor: 5.033

4.  Rapamycin-treated human endothelial cells preferentially activate allogeneic regulatory T cells.

Authors:  Chen Wang; Tai Yi; Lingfeng Qin; Roberto A Maldonado; Ulrich H von Andrian; Sanjay Kulkarni; George Tellides; Jordan S Pober
Journal:  J Clin Invest       Date:  2013-03-08       Impact factor: 14.808

Review 5.  Inhibition of the interleukin-6 signaling pathway: a strategy to induce immune tolerance.

Authors:  Cheng Zhang; Xi Zhang; Xing-Hua Chen
Journal:  Clin Rev Allergy Immunol       Date:  2014-10       Impact factor: 8.667

6.  Cytokine and autoantibody patterns in acute liver failure.

Authors:  Jinze Li; Xu Zhu; Feng Liu; Ping Cai; Corron Sanders; William M Lee; Jack Uetrecht
Journal:  J Immunotoxicol       Date:  2010 Jul-Sep       Impact factor: 3.000

Review 7.  Balancing Inflammation: The Link between Th17 and Regulatory T Cells.

Authors:  Maggie L Diller; Ragini R Kudchadkar; Keith A Delman; David H Lawson; Mandy L Ford
Journal:  Mediators Inflamm       Date:  2016-06-19       Impact factor: 4.711

8.  IL-17A polymorphism (rs2275913) and levels are associated with preeclampsia pathogenesis in Chinese patients.

Authors:  Xiao Lang; Wei Liu; Yanyan Hou; Wenxia Zhao; Xingyu Yang; Lan Chen; Qi Yan; Weiwei Cheng
Journal:  BMC Med Genomics       Date:  2021-01-06       Impact factor: 3.063

9.  A higher risk of acute rejection of human kidney allografts can be predicted from the level of CD45RC expressed by the recipients' CD8 T cells.

Authors:  Laurence Ordonez; Isabelle Bernard; Marianne Chabod; Jean-François Augusto; Valerie Lauwers-Cances; Christelle Cristini; Maria-Cristina Cuturi; Jean-François Subra; Abdelhadi Saoudi
Journal:  PLoS One       Date:  2013-07-24       Impact factor: 3.240

10.  Therapeutic Potential of Targeting Malt1-Dependent TCR Downstream Signaling to Promote the Survival of MHC-Mismatched Allografts.

Authors:  Lerisa Govender; Josip Mikulic; Jean-Christophe Wyss; Olivier Gaide; Margot Thome; Dela Golshayan
Journal:  Front Immunol       Date:  2020-09-11       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.